Validated GC–MS analysis for the determination of residual fentanyl in applied Durogesic® reservoir and Durogesic® D-Trans® matrix transdermal fentanyl patches - ScienceDirect
Por um escritor misterioso
Descrição
Development and evaluation of a tampering resistant transdermal fentanyl patch - ScienceDirect
Predicting transdermal fentanyl delivery using physics-based simulations for tailored therapy
Predicting transdermal fentanyl delivery using mechanistic simulations for tailored therapy
Predicting transdermal fentanyl delivery using mechanistic simulations for tailored therapy
These highlights do not include all the information needed to use FENTANYL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for FENTANYL TRANSDERMAL SYSTEM. FENTANYL transdermal system CIIInitial U.S. Approval: 1968
Validated GC-MS analysis for the determination of residual fentanyl in applied Durogesic (R) reservoir and Durogesic (R) D-Trans (R) matrix transdermal fentanyl patches
Validated GC-MS analysis for the determination of residual fentanyl in applied Durogesic (R) reservoir and Durogesic (R) D-Trans (R) matrix transdermal fentanyl patches
Frontiers Predicting Transdermal Fentanyl Delivery Using Mechanistic Simulations for Tailored Therapy
Identification of volatile components in the headspace of pharmaceutical-grade fentanyl - ScienceDirect
Evaluation of a lateral flow immunoassay for the detection of the synthetic opioid fentanyl - ScienceDirect
Frontiers Predicting Transdermal Fentanyl Delivery Using Mechanistic Simulations for Tailored Therapy
Evaluation of a lateral flow immunoassay for the detection of the synthetic opioid fentanyl - ScienceDirect
Comparison of adhesion and dissolution of fentanyl patches: Fentadur® and Durogesic DTrans®
FENTANYL TRANSDERMAL SYSTEM 25 mcg/hr, 50 mcg/hr, 75 mcg/hr, 100 mcg/hr CII Full Prescribing Information Rx only FOR USE IN OPIOID-TOLERANT PATIENTS ONLY
de
por adulto (o preço varia de acordo com o tamanho do grupo)
